tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Evans, 1 are a BUY (100%).
Analyst David Evans, currently employed at KEPLER CHEUVREUX, carries an average stock price target met ratio of 100% that have a potential upside of 31.55% achieved within 230 days.
David Evans’s has documented 2 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVS, Novartis AG ADR at 07-Sep-2022.
Analyst best performing recommendations are on NVS (NOVARTIS AG ADR).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) at 9/7/2022. The price target of $92.78 was fulfilled within 230 days with a profit of $22.25 (31.55%) receiving and performance score of 1.37.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$120
$5.71 (5.00%)
$118
6 months 10 days ago
(30-Oct-2024)
3/4 (75%)
$10.09 (9.18%)
110
Hold
$122.5
8 months 7 days ago
(03-Sep-2024)
6/8 (75%)
$16.06 (15.09%)
401
Hold
$95.34
1 years 16 days ago
(24-Apr-2024)
13/13 (100%)
$2.73 (2.95%)
580
$109
$-5.29 (-4.63%)
$114
1 years 2 months 24 days ago
(16-Feb-2024)
15/15 (100%)
$12.5 (12.95%)
892
Sell
$90.02
$-24.27 (-21.24%)
$100.71
1 years 6 months 17 days ago
(23-Oct-2023)
4/4 (100%)
$-1.19 (-1.30%)
161
What Year was the first public recommendation made by David Evans?
